Gregory Cash has been appointed president and CEO of US-based pain management device company NeuroTherm.
He joins from HeartSine Technologies, where he also served as president and CEO.
“This is a key appointment at an important time for NeuroTherm, and we are certain that Greg's leadership combined with his strategic vision and experience make him the right person to lead the company through the next phase of rapid growth and development,” said Eric Bacon, chair of the board of directors at NeuroTherm.
Prior to his time at HeartSine, Cash served in numerous senior management roles of progressive responsibility in the US, Asia and Europe.
“While there are many challenges facing the medical device industry as a whole, NeuroTherm is poised for strong growth and will continue to make a positive difference in patients' lives,” said Cash.